Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
Adam D. Cohen, MD

Adam D. Cohen, MD Physician

Director, Myeloma Immunotherapy Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Cohen is employed by Penn Medicine.

About Dr. Adam D. Cohen

Recognized by America's Top Doctors for 2017

Recognized by Best Doctors in America 2016

Recognized in Philadelphia magazine's May 2018 Top Docs issue

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Specialty:

  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 2007
  • Medical Oncology, 2005

Clinical Expertise:

  • Autologous Stem Cell Transplantation
  • Lymphoma
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia (WM)

Description of Clinical Expertise

Multiple Myeloma
Amyloidosis
POEMS syndrome
Monoclonal gammopathies
Waldenstrom's Macroglobulinemia

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: University of Pennsylvania School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: Memorial Sloan-Kettering Cancer Center

Memberships

American Association for Cancer Research, National American Society of Clinical Oncology, National American Society of Hematology, National Eastern Cooperative Oncology Group, National Independent Data and Safety Monitoring Committee, "Griffin" randomized trial of Daratumumab-RVD vs RVD for newly-diagnosed myeloma (NCT02874742), International International Myeloma Society, International International Myeloma Working Group (IMWG), International

Hospital Affiliation

Dr. Cohen is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Cancer immunotherapy
Vaccines
Cellular therapy
Phase I trials
CAR T cells

Selected Publications:

Adam D. Cohen*, Nikoletta Lendvai*, Sarah Nataraj, Naoko Imai, Achim A. Jungbluth, Ioanna Tsakos, Adeeb Rahman, Anna Huo-Chang Mei, Herman Singh, Katarzyna Zarychta, Seunghee Kim-Schulze, Andrew Park, Ralph Venhaus, Katherine Alpaugh, Sacha Gnjatic, and Hearn J. Cho: Autologous lymphocyte infusion supports tumor antigen vaccine-induced immunity in autologous stem cell transplant for multiple myeloma Cancer Immunology Research : 2019.

Luca Bernabei, Alfred L. Garfall, J. Joseph Melenhorst, Simon F Lacey, Edward A. Stadtmauer, Dan T. Vogl, Vanessa Gonzalez, Gabriela Plesa, Regina M Young, Adam Waxman, Bruce L Levine, Carl H June, Michael C. Milone, and Adam D. Cohen: PD-1 Inhibitor Combinations As Salvage Therapy for Relapsed/Refractory Multiple Myeloma (MM) Patients Progressing after BCMA-Directed CAR T Cells Blood, ASH Annual Meeting, San Diego, CA 132 : #1973,2018.

Tara Gregory, Adam D. Cohen, Caitlin L. Costello, Syed Abbas Ali, Jesus G. Berdeja, Eric M Ostertag, Christopher Martin, Devon J Shedlock, Michelle Lynn Resler, Matthew A. Spear, Robert Z. Orlowski, and Krina K. Patel: Efficacy and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) Blood, ASH Annual Meeting, San Diego, CA 132 : #1012,2018.

Adam D. Cohen, J. Joseph Melenhorst, Alfred L. Garfall, Simon F Lacey, Megan Davis, Dan T. Vogl, Lifeng Tian, Vanessa Gonzalez, Iulian Pruteanu, Anne Marie Nelson, Gabriela Plesa, Adam Waxman, Regina M Young, Bruce L Levine, Carl H June, Edward A. Stadtmauer, and Michael C. Milone: Predictors of T Cell Expansion and Clinical Responses Following B-Cell Maturation Antigen-Specific Chimeric Antigen Receptor T Cell Therapy (CART-BCMA) for Relapsed/Refractory Multiple Myeloma (MM) Blood, ASH Annual Meeting, San Diego, CA 132 : #1974,2018.

Ehren Dancy, Alfred L. Garfall, Adam D. Cohen, Joseph A Fraietta, Megan Davis, Bruce L Levine, Don L. Siegel, Edward A. Stadtmauer, Dan T. Vogl, Adam Waxman, Aaron P. Rapoport, Michael C. Milone, Carl H June, and J. Joseph Melenhorst: Clinical Predictors of T Cell Fitness for CAR T Cell Manufacturing and Efficacy in Multiple Myeloma Blood, ASH Annual Meeting, San Diego, CA 132 : #1886,2018.

Trudel S, Lendvai N, Popat R, Voorhees PM, Reeves B, Libby EN, Richardson PG, Anderson Jr. LD, Sutherland HJ, Yong K, Hoos A, Gorczyca MM, Lahiri S, He Z, Austin DJ, Opalinska JB, Cohen AD: Targeting B-Cell Maturation Antigen with GSK2857916 Antibody-Drug Conjugate in Relapsed or Refractory Multiple Myeloma: A Dose-Escalation and Expansion Phase 1 Trial (BMA117159) Lancet Oncology pii: S1470-2045 (18): 30576-X,2018.

Gumber Ramnika, Cohen Jordana B, Palmer Matthew B, Kobrin Sidney M, Vogl Dan T, Wasserstein Alan G, Nasta Sunita D, Bleicher Melissa B, Bloom Roy D, Dember Laura, Cohen Adam, Weiss Brendan M, Hogan Jonathan J: A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Kidney international 94 (1): 199-205,2018.

Cohen Adam D: CAR T Cells and Other Cellular Therapies for Multiple Myeloma: 2018 Update. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting (38): e6-e15,2018.

Garfall Alfred L, Stadtmauer Edward A, Hwang Wei-Ting, Lacey Simon F, Melenhorst Jan Joseph, Krevvata Maria, Carroll Martin P, Matsui William H, Wang Qiuju, Dhodapkar Madhav V, Dhodapkar Kavita, Das Rituparna, Vogl Dan T, Weiss Brendan M, Cohen Adam D, Mangan Patricia A, Ayers Emily C, Nunez-Cruz Selene, Kulikovskaya Irina, Davis Megan M, Lamontagne Anne, Dengel Karen, Kerr Naseem Ds, Young Regina M, Siegel Donald L, Levine Bruce L, Milone Michael C, Maus Marcela V, June Carl H: Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. JCI insight 3 (8): 2018.

Waxman Adam J, Clasen Suparna, Hwang Wei-Ting, Garfall Alfred, Vogl Dan T, Carver Joseph, O'Quinn Rupal, Cohen Adam D, Stadtmauer Edward A, Ky Bonnie, Weiss Brendan M: Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis. JAMA oncology 4 (3): e174519,2018.

Academic Contact Info

Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-175
3400 Civic Center Blvd


Philadelphia, PA 19104
Phone: (215) 615-5853
Patient appointments: 800-789-7366 (PENN)